Intralesional injection of mitomycin C following visual internal urethrotomy for recurrent urethral stricture: a randomized controlled study

Abstract

Aim:

To assess the efficacy of Intralesional injection of mitomycin C (MMC) following visual internal urethrotomy (VIU) in the management of recurrent urethral stricture.

Materials:

Fifty male patients diagnosed with recurrent single bulbar urethral stricture measuring less than 1.5 cm previously treated with VIU were randomly allocated into two equal groups, (Group A) planned for VIU only and (Group B) planned for VIU with intralesional MMC injection using Botox injection needle. All patients were objectively evaluated pre- and post-operatively at 3, 6, and 12 months using uroflowmetry, post-void residual urine volume, and retrograde urethrography.

Results:

Forty-five patients completed their follow-up in our study. Patients who underwent intralesional MMC injection showed significant improvement in uroflowmetry, post-voiding residual, and with a success rate (82.6% in Group B, compared to 50% in Group A with a highly statistically significant difference, p-value: <0.001). VIU with MMC was the only factor associated with a marked decrease in stricture recurrence (p = 0.02) as shown in the Multivariate Cox regression analysis.

Conclusion:

Intralesional injection of mitomycin C seems to be a safe and effective modality in reducing the recurrent stricture rate after VIU.

Keywords

Mitomycin C visual internal urethrotomy urethral stricture outflow obstruction uroflowmetry urethra

Get full access to this article

View all access options for this article.

References

Latini

McAninch

Brandes

, et al. SIU/ICUD consultation on urethral strictures: epidemiology, etiology, anatomy, and nomenclature of urethral stenoses, strictures, and pelvic fracture urethral disruption injuries. Urology 2014; 83(3): S1–S7.

Gamal

Higazy

Ebskharoun

, et al. Holmium: YAG versus cold knife internal urethrotomy in the management of short urethral strictures: a randomized controlled trial. J Lasers Med Sci 2021; 12(1): e35.

Noureldin

Fathy

Ahmed

, et al. Intralesional injection of mitomycin C following internal urethrotomy of de novo bulbar urethral stricture: new experience using a novel adjustable-tip needle. Arab J Urol 2021; 19(4): 473–479.

Mazdak

Meshki

Ghassami

. Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy. Eur Urol 2007; 51(4): 1089–1092.

Al Taweel

Seyam

. Visual internal urethrotomy for adult male urethral stricture has poor long-term results. Adv Urol 2015; 2015: 1–4.

Bayne

Gaither

Awad

, et al. Guidelines of guidelines: a review of urethral stricture evaluation, management, and follow-up. Transl Androl Urol 2017; 6(2): 288–294.

Wessells

Morey

Souter

, et al. Urethral stricture disease guideline amendment (2023). J Urol 2023; 210(1): 64–71.

Farrell

Lawrenz

Levine

. Internal urethrotomy with intralesional mitomycin C: an effective option for endoscopic management of recurrent bulbar and bulbomembranous urethral strictures. Urology 2017; 110: 223–227.

Ali

Shahzad

Orakzai

, et al. Efficacy of mitomycin C in reducing recurrence of anterior urethral stricture after internal optical urethrotomy. Korean J Urol 2015; 56(9): 650.